Nutritional Risk Status Predicts Overall Survival of Mexican Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Campos-Gomez, S. [1 ]
Valdez-Andrade, J. J. [1 ]
Esquivel-Gutierrez, J. [1 ]
Jaimes Alpizar, E. [1 ]
Pacheco-Cuellar, G. [1 ]
Campos-Gomez, K. [1 ]
机构：
[1] Ctr Oncol Estatal Issemym, Thorac Oncol Unit, Toluca De Lerdo, Mexico
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
nutrition risk; lung cancer; prognosis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P09.11
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [1] Overall survival benefit in advanced non-small-cell lung cancer
    Owen, Olwen Glynn
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (07) : 379 - 379
  • [2] Can Nutritional Status Predict Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer?
    Seo, Youngkwang
    Eo, Wankyu
    Kim, Sehyun
    Shim, Bumsang
    Lee, Sookyung
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2019, 71 (07): : 1108 - 1117
  • [3] Time trends in overall survival (OS) gain in advanced non-small-cell lung cancer (NSCLC).
    Saad, Everardo D.
    Buyse, Marc E.
    Jassem, Jacek
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Role of time to progression as a surrogate marker for overall survival in patients with advanced non-small-cell lung cancer (NSCLC)
    Hotta, K.
    Kiura, K.
    Fujiwara, Y.
    Takigawa, N.
    Tabata, M.
    Ueoka, H.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] EGFR Status, Risk Factors for Brain Metastases and Overall Survival in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
    Chowdhury, M.
    Hueniken, K.
    Schmid, S.
    Brown, C.
    Khan, K.
    Walia, P.
    Sabouhanian, A.
    Strom, E.
    Herman, J.
    Xu, W.
    Leighl, N.
    Bradbury, P.
    Sacher, A.
    Shepherd, F.
    Liu, G.
    Shultz, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S625 - S626
  • [6] Nutritional and functional status impairments to predict early death in elderly patients with advanced non-small-cell lung cancer (NSCLC).
    Luciani, Andrea
    Careri, Carmela
    Bocci, Barbara
    Violati, Martina
    Guidi, Alessandro
    Blasi, Miriam
    Bordin, Veronica
    Caldiera, Sarah
    Zonato, Sabrina
    Ferrari, Daris
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Nondisruptive mutations of TP53 and overall survival (OS) in advanced non-small-cell lung cancer (NSCLC) patients (p)
    Costa, Enric Carcereny
    Bertran-Alamillo, Jordi
    Molina-Vila, Miguel Angel
    Gervais, Radj
    Massuti, Bartomeu
    Bonanno, Laura
    Moran, Teresa
    Majem, Margarita
    Felip, Enriqueta
    Garcia-Campelo, M. Rosario
    Vergnenegre, Alain
    Ramirez, Santiago Viteri
    Gasco, Amaya
    Wannesson, Luciano
    Mayo-de las Casas, Clara
    Pujantell-Pastor, Laia
    Favaretto, Adolfo G.
    Karachaliou, Niki
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Relative Dose Intensity of First-Line Chemotherapy and Overall Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Denduluri, Neelima
    Patt, Debra
    Jiao, Xiaolong
    Morrow, Phuong
    Garcia, Jacob
    Barron, Rich
    Crawford, Jeffrey
    Lymans, Gary
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S891 - S892
  • [9] Impact of prophylactic Cranial Irradiation on Overall Survival of Patients with advanced non-small-cell Lung Cancer
    Schmidt, Julia
    Appold, Steffen
    Troost, Esther G. C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (05) : 453 - 455
  • [10] Cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Pirker, Robert
    LUNG CANCER, 2012, 77 : S13 - S14
12345